Recalls

• Mar 2, 2008 1:59 pm US/Eastern
• Digg | Facebook | E-mail

  Close WindowE-mail This Page

  Florida Company Recalls Sexual Enhancement Drug

  Required fields are marked with an asterisk(*)

  ---

  • Recipient E-mail:* 
  • • Your Name:* 
    • Your E-mail:* 
  • Add a Message:
  •   Send me a copy of this e-mail.

  • Type the characters in this picture:* Click here to refresh with new letters

  ---

  The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications. Read more in our Privacy Policy

  Send E-mail

  | Print

Florida Company Recalls Sexual Enhancement Drug

Recall Affects Aspire36 And Aspire Lite

Customers Can Call Palo Alto Labs At (877) 240-3340

PORT ST. LUCIE (CBS4) ― A Florida based company is recalling thousands of packages of a male sexual enhancement drug because it contains a substance that could be harmful to certain men.

The recall affects Aspire36 and Aspire Lite manufactured by Palo Alto Labs of Port St. Lucie. The drugs, distributed on the internet, were either sold in a blister pack containing one liquid capsule or a bottle containing either three or 12 liquid capsules.

The Food and Drug Administration said in the samples they tested, the drug contained an active ingredient similar to an FDA-approved drug for erectile dysfunction. The chemical could pose a threat to certain users because it may interact with nitrates found in some prescription drugs and may lower blood pressure to dangerous levels.

Customers who've bought the product are asked to stop using it immediately and contact their doctor if they have experienced any problems that may be related to taking this product.

Any reactions should be reported to the FDA's MedWatch adverse event reporting program.

For more information, customers can call the company at 1-877-240-3340.

(© 2008 CBS Broadcasting Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press contributed to this report.)

---